scholarly journals New standardized nursing cooperation workflow to reduce stroke thrombolysis delays in patients with acute ischemic stroke

2017 ◽  
Vol Volume 13 ◽  
pp. 1215-1220 ◽  
Author(s):  
Yan Zhou ◽  
Zhuojun Xu ◽  
Jiali Liao ◽  
Fangming Feng ◽  
Lai Men ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Acute Ischemic Stroke ◽  
Stroke Thrombolysis

Should Tenecteplase be Given in Clinical Practice for Acute Ischemic Stroke Thrombolysis?

Stroke ◽  
2021 ◽  
Author(s):  
Jukka Putaala ◽  
Jeffrey L. Saver ◽  
May Nour ◽  
Dawn Kleindorfer ◽  
Mollie McDermott ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Clinical Practice ◽  
Acute Ischemic Stroke ◽  
Stroke Thrombolysis

scholarly journals Alteplase for acute ischemic stroke: 2 years in a community hospital without previous experience in stroke thrombolysis

Critical Care ◽  
2008 ◽  
Vol 12 (Suppl 2) ◽  
pp. P127
Author(s):  
A Estella ◽  
A Sainz de Baranda ◽  
E Moreno ◽  
MJ Galan ◽  
E Leal ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Acute Ischemic Stroke ◽  
Community Hospital ◽  
Previous Experience ◽  
Stroke Thrombolysis

MSC 2021 Virtual E-Abstract

2021 ◽  
Vol 3 (3) ◽  
pp. 37-42
Author(s):  
Malaysian Stroke Conference
Keyword(s):  
Growth Hormone ◽  
Ischemic Stroke ◽  
Acute Ischemic Stroke ◽  
Healthcare Providers ◽  
Hormone Deficiency ◽  
Therapeutic Effects ◽  
Diagnostic Dilemma ◽  
Brain Recovery ◽  
Stroke Thrombolysis

1. Factors Influencing The Uptake Of Stroke Thrombolysis In Malaysia: A Case Study From The Healthcare Providers’ Perspective.2. Growth Hormone And Ischemic Stroke: Focus On Growth Hormone Deficiency And Therapeutic Effects Of Growth Hormone On Brain Recovery.3. Predictors Of Post-Thrombolysis Intracerebral Haemorrhage In Patients With Acute Ischemic Stroke.4. Predictors of Mortality In Thrombolysed Acute Ischemic Stroke Patients of Seberang Jaya Hospital.5. Bilateral Dejerine Syndrome: A Case Report with Diagnostic Dilemma.6. Outcome Of Ischemic Stroke Thrombolysis Treatment In Seberang Jaya Hospital, A Single Center 9 Years Review: 2012-2020.

PREDICTORS THE RISK OF SYMPTOMATIC INTRACEREBRAL HEAMORHAGE AFTER THROMBOLYTIC THERAPY WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR IN ACUTE ISCHEMIC STROKE

2017 ◽  
pp. 64-67
Author(s):  
Dinh Thuyen Nguyen ◽  
Duy Ton Mai ◽  
Viet Phuong Dao ◽  
Anh Tuan Nguyen
Keyword(s):  
Ischemic Stroke ◽  
Thrombolytic Therapy ◽  
Acute Ischemic Stroke ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Recombinant Tissue Plasminogen Activator ◽  
Brain Ct ◽  
Tissue Plasminogen ◽  
History Of ◽  
Stroke Thrombolysis

Objective: to evaluate predictors the risk of symptomatic intracerebral heamorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke. Methods: observative study on 54 patients with acute ischemic stroke at Emergency Department, Bach Mai hospital from 01/2010 to 10/2016. Results: Predictors the risk of symptomatic intracerebral heamorrhage were: age above 70 (OR 2,76; 95% CI 0,73 – 10,52; p = 0,12), time from onset to treatment (OR 1,03; 95% CI 0,34 – 3,13; p = 0,95), systolic blood pressure ≥ 140 mmHg (OR 2,0; 95% CI 0,61 – 6,51; p = 0,24), NIHSS score above 12 (OR 3,13; 95% CI 0,63 – 15,51; p = 0,138), glycemia above 10 mmol/l (OR 8,94; 95% CI 1,51 – 51,73; p = 0,003), fibrillation atrial (OR 1,49; 95% 0,49 – 4,56; p = 0,33), history of diebete (OR 6,4; 95% CI 0,67 – 61,03; p = 0,06), history of anticoagulation (OR 1,07; 95% CI 0,22 – 5,11; p = 0,63), history of cerebral infarction (OR 1,49; 95% CI 0,183 – 12,184; p = 0,707), sign of early brain CT (OR 6,14; 95% CI 1,01 – 39,93; p = 0,048). Conclusion: glucose above 10 mmol/l and sign of early brain CT were predictors the risk of symptomatic intracerebral heamorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke. Key words: stroke, thrombolysis, predictor, heamorrhage conversion

scholarly journals Acute stroke thrombolysis in infective endocarditis

2018 ◽  
Vol 6 ◽  
pp. 2050313X1880762 ◽  
Author(s):  
Abdulaziz Ashkanani ◽  
Zouhair Bitar ◽  
Osama Maadrani
Keyword(s):  
Ischemic Stroke ◽  
Infective Endocarditis ◽  
Acute Ischemic Stroke ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Recombinant Tissue Plasminogen Activator ◽  
Hemorrhagic Transformation ◽  
Successful Outcome ◽  
Tissue Plasminogen ◽  
Stroke Thrombolysis

Intravenous recombinant tissue plasminogen activator is not recommended for the treatment of acute ischemic stroke in patients with infective endocarditis due to the risk of hemorrhagic transformation of septic emboli and few reported cases in the literature. Here, we present the successful outcome of intravenous recombinant tissue plasminogen activator administration for a patient with acute ischemic stroke who was later found to have infective endocarditis. This case adds to the small number of cases reported in the literature.

Sign in / Sign up

Export Citation Format

Share Document